Natural killer (NK) cells circulate through the blood, lymphatics and tissues, on patrol for the presence of transformed or pathogen-infected cells. As almost all NK cell receptors bind to host-encoded ligands, signals are constantly being transmitted into NK cells, whether they interact with normal or abnormal cells. The sophisticated repertoire of activating and inhibitory receptors that has evolved to regulate NK cell activity ensures that NK cells protect hosts against pathogens, yet prevents deleterious NK cell-driven autoimmune responses. Here I highlight recent advances in our understanding of the structural properties and signaling pathways of the inhibitory and activating NK cell receptors, with a particular focus on the ITAM-dependent activating receptors, the NKG2D-DAP10 receptor complexes and the CD244 receptor system. NK cells, like other members of the innate immune system, were once considered nonspecific in their interactions with tumors or virus-infected cells. A seminal study noted that NK cells can kill certain tumor cells lacking MHC class I, yet spare the same tumors expressing MHC class I (ref. 1). This ability to attack cells 'missing self' predicted the existence of inhibitory receptors on NK cells, and it revealed the mechanism whereby NK cells engage in surveillance for transformed or virus-infected cells that have downregulated expression of MHC class I in an effort to avoid recognition by CD8 + cytotoxic T lymphocytes. However, missing from the missing-self hypothesis was any molecular basis for how NK cells are activated when they encounter tumors or virus-infected cells, or how in certain circumstances NK cells do efficiently recognize and kill tumors or virus-infected cells that maintain expression of MHC class I. Even after the discovery of the inhibitory NK cell receptors, activation of NK cells against MHC class I-deficient cells was generally considered nonspecific. Not so anymore. Many activating NK cell receptors and pathways have recently been identified, and the interplay between the inhibitory receptors and activating receptors are being defined. This review highlights the predominant signaling pathways that regulate the responses of NK cells encountering potential target cells.
Inhibitory NK receptorsNK cells express a repertoire of inhibitory receptors that regulate their activation. Some inhibitory NK receptors are specific for MHC class I, whereas others bind non-MHC ligands (Supplementary Table 1 online). Some of these inhibitory NK receptors, such as killer cell immunoglobulin-like receptors (KIRs) and leukocyte immunoglobulin-like receptors (LILRs), are monomeric type I glycoproteins of the immunoglobulin superfamily, whereas others, suchCorrespondence should be addressed to L.L.L. (E-mail: lewis.lanier@ucsf.edu).. Note: Supplementary information is available on the Nature Immunology website.
COMPETING INTERESTS STATEMENTThe author declares competing financial interests: details accompany the full-text HTML version of the paper at http://www.nature.com/natur...